Health ❯Medications

Weight Loss Drugs

Ozempic GLP-1 Agonists Semaglutide Wegovy Zepbound Side Effects Tirzepatide GLP-1 Drugs GLP-1 Receptor Agonists GLP-1 Medications GLP-1 GLP-1s

CDC Reports Nearly 25,000 ER Visits Linked to Semaglutide in Two Years

New data highlights gastrointestinal complications as the leading cause of adverse events from popular weight-loss drugs like Ozempic and Wegovy.

Karan Johar Refutes Ozempic Rumors, Shares Weight Loss Journey

Widespread Use of Weight-Loss Drugs Redefines Health, Beauty, and Access

Megan Stalter Criticizes Ozempic Use for Weight Loss

GLP-1 Weight Loss Drugs Surge in Popularity Amidst Stigma and Cultural Shifts

Study Investigates Vision Loss in Patients Using Popular Diabetes and Weight Loss Drugs

Super Bowl Ad for Compounded Weight Loss Drugs Draws Criticism Over Safety and Regulation

Navigating Thanksgiving on Weight-Loss Drugs: Expert Advice on Food Choices

FDA Declares End to Tirzepatide Shortage, Impacting Compounded Drug Market

James Corden Reveals Ozempic Failed to Address His Food Addiction

Tory Leadership Contender Robert Jenrick Discusses Weight Loss Journey

Ozempic's Expanding Role: Beyond Diabetes and Weight Loss

Weight-Loss Drug Market Expands with New Generic Versions

Eli Lilly Invests $9 Billion to Boost Production of Weight Loss Drugs

Novo Nordisk to Investigate Ozempic's Impact on Alcohol Consumption

Jamie-Lynn Sigler Criticizes Ozempic Use Among the Healthy

Eli Lilly's Weight-Loss Drug Zepbound Now Available in U.S. Pharmacies

Weight Loss Drug Wegovy Reduces Heart Attack and Stroke Risk, Study Finds

Popular weight loss drugs linked to rare but serious gastrointestinal side effects

Interest high but caveats remain for new weight loss drugs